Neuroscience

Two public panel discussions in Jupiter, Florida, will explore new discoveries about the brain and brain health.

A Parkinson's disease project from the lab of chemist Matthew D. Disney, Ph.D., has received a boost from a nonprofit focused on helping scientists translate their discoveries into treatments.

Children born with a damaged gene needed for healthy brain development, SYNGAP1, experience seizures, sensory processing disorders, difficulty speaking, intellectual disability, and autism-like behaviors. It’s a condition without any treatments, one that’s hard both on parents and children, said Gavin Rumbaugh, Ph.D., a neuroscientist at The Herbert Wertheim…

Scripps Research awarded doctoral degrees to 59 graduate students, including eight from its partner program based at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, during its 32nd commencement.

A specialized RNA with a memorable acronym, SLAMR, plays a role in fear conditioning, according to a discovery from scientists led by Sathya Puthanveettil, Ph.D..

Molecular biologist Ezgi Hacisuleyman, Ph.D., investigates how neurons respond to signals, changing in milliseconds. She recently joined the institute from The Rockefeller University.

Hattori focuses on understanding and mapping how the brain integrates information to make decisions.

Seminars on collagen structure and vesicle trafficking sparked thoughtful discussion during chemistry and neuroscience department talks in January.

Predicting who could benefit from a given drug has been difficult. An international team led by neuroscientist Kirill Martemyanov, Ph.D., is training AI to assist.

Ten graduate students who completed their doctoral studies on The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology campus in Jupiter were honored today, Friday, May 19, during Scripps Research’s 31st Commencement Ceremony in La Jolla, California. Hosted by the Skaggs Graduate School…